Close
Tirasemtiv not found effective for treatment of MND

Tirasemtiv not found effective for treatment of MND

Reading Time: 2 minutes In their official press release published on 21 November 2017, Cytokinetics Inc. announced that they will not be continuing work on tirasemtiv after disappointing results in the latest Phase 3 clinical trial. The trial, known under the acronym ‘VITALITY-ALS’, tested whether the drug has a beneficial effect on the breathing function and muscle strength of…

Tirasemtiv Phase II clinical trial – results

Reading Time: 4 minutes The top-line results from the Cytokinetics Inc Phase IIb clinical trial of Tirasemtiv were announced last week. Following this announcement, detailed results were then presented on 29 April 2014 at the Annual Academy of Neurology (AAN) meeting. Unfortunately, although the drug was found to be safe, the results concluded that Tirasemtiv did not meet its…